Comparison of three prognostic models for predicting cancer-specific survival among patients with gastrointestinal stromal tumors
Aim: To evaluate the predictive value for cancer-specific survival of the models of the American Joint Committee on Cancer (AJCC) stage, NIH and Armed Forces Institute of Pathology (AFIP) among patients with gastrointestinal stromal tumors (GISTs). Methods: Surveillance, Epidemiology and End Results...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
10 Jan 2018
|
| In: |
Future oncology
Year: 2018, Jahrgang: 14, Heft: 4, Pages: 379-389 |
| ISSN: | 1744-8301 |
| DOI: | 10.2217/fon-2017-0450 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2217/fon-2017-0450 Verlag, lizenzpflichtig, Volltext: https://www.futuremedicine.com/doi/10.2217/fon-2017-0450 
|
| Verfasserangaben: | Hani Oweira, Jan Schmidt, Arianeb Mehrabi, Hasan Kulaksiz, Paul Schneider, Othmar Schöb, Anwar Giryes, Omar Abdel-Rahman |
| Zusammenfassung: | Aim: To evaluate the predictive value for cancer-specific survival of the models of the American Joint Committee on Cancer (AJCC) stage, NIH and Armed Forces Institute of Pathology (AFIP) among patients with gastrointestinal stromal tumors (GISTs). Methods: Surveillance, Epidemiology and End Results database (2010-2014) was accessed. Overall survival analysis and adjusted cancer-specific Cox regression hazard was calculated. Results: For gastric GISTs, concordance-index according to AJCC was 0.834; according to NIH was 0.833; according to AFIP was 0.836. Concordance-index for nongastric GISTs according to AJCC was 0.800, according to NIH was 0.801 and according to AFIP was 0.799. Conclusion: The performance of the three models is comparable with regards to cancer-specific survival prediction. |
|---|---|
| Beschreibung: | Gesehen am 11.03.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1744-8301 |
| DOI: | 10.2217/fon-2017-0450 |